Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult‐Onset Degenerative Ataxia
Movement Disorders · 2023-04 · 38 (4) · 654-664
DOI: 10.1002/mds.29324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 25.01.2023. Verfasst von Demet Oender und 27 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Multiple System Atrophy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Tübingen.
Abstract (Originalsprache)
Background
Sporadic adult‐onset ataxias without known genetic or acquired cause are subdivided into multiple system atrophy of cerebellar type (MSA‐C) and sporadic adult‐onset ataxia of unknown etiology (SAOA).
Objectives
To study the differential evolution of both conditions including plasma neurofilament light chain (NfL) levels and magnetic resonance imaging (MRI) markers.
Methods
SPORTAX is a prospective registry of sporadic ataxia patients with an onset >40 years. Scale for the Assessment and Rating of Ataxia was the primary outcome measure. In subgroups, blood samples were taken and MRIs performed. Plasma NfL was measured via a single molecule assay. Regional brain volumes were automatically measured. To assess signal changes, we defined the pons and middle cerebellar peduncle abnormality score (PMAS). Using mixed‐effects models, we analyzed changes on a time scale starting with ataxia onset.
Results
Of 404 patients without genetic diagnosis, 130 met criteria of probable MSA‐C at baseline and 26 during follow‐up suggesting clinical conversion to MSA‐C. The remaining 248 were classified as SAOA. At baseline, NfL, cerebellar white matter (CWM) and pons volume, and PMAS separated MSA‐C from SAOA. NfL decreased in MSA‐C and did not change in SAOA. CWM and pons volume decreased faster, whereas PMAS increased faster in MSA‐C. In MSA‐C, pons volume had highest sensitivity to change, and PMAS was a predictor of faster progression. Fulfillment of possible MSA criteria, NfL and PMAS were risk factors, CWM and pons volume protective factors for conversion to MSA‐C.
Conclusions
This study provides detailed information on differential evolution and prognostic relevance of biomarkers in MSA‐C and SAOA. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- Department of Neurology, University Hospital Bonn, Bonn, Germany.
- Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- Department of Neuroradiology, University Hospital Bonn, Bonn, Germany.
- German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
ORCID-Profile: Carlo Wilke, Marcus Grobe-Einsler, Christoph Kamm, Matthis Synofzik, Thomas Klockgether
Förderung
- University of Tübingen
Zitieren
APA
Oender, D., Faber, J., Wilke, C., Schaprian, T., Lakghomi, A., Mengel, D., Schöls, L., Traschütz, A., Fleszar, Z., Dufke, C., Vielhaber, S., Machts, J., Giordano, I., Grobe-Einsler, M., Klopstock, T., Stendel, C., Boesch, S., Nachbauer, W., Timmann-Braun, D., …, & Klockgether, T. (2023). Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult‐Onset Degenerative Ataxia. Movement Disorders, 38(4), 654-664. https://doi.org/10.1002/mds.29324
Vancouver
Oender D, Faber J, Wilke C, Schaprian T, Lakghomi A, Mengel D, et al. Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult‐Onset Degenerative Ataxia. Movement Disorders. 2023;38(4):654-664. doi:10.1002/mds.29324
BibTeX
@article{Oender2023,
author = {Oender, Demet and Faber, Jennifer and Wilke, Carlo and Schaprian, Tamara and Lakghomi, Asadeh and Mengel, David and Schöls, Ludger and Traschütz, Andreas and Fleszar, Zofia and Dufke, Claudia and Vielhaber, Stefan and Machts, Judith and Giordano, Ilaria and Grobe-Einsler, Marcus and Klopstock, Thomas and Stendel, Claudia and Boesch, Sylvia and Nachbauer, Wolfgang and Timmann-Braun, Dagmar and Thieme, Andreas Gustafsson and Kamm, Christoph and Dudesek, Ales and Tallaksen, Chantal and Wedding, Iselin and Filla, Alessandro and Schmid, Matthias and Synofzik, Matthis and Klockgether, Thomas},
title = {Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult‐Onset Degenerative Ataxia},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {4},
pages = {654--664},
doi = {10.1002/mds.29324}
}
EUVIMED